article thumbnail

Addressing increasingly resistant drugs by infectious agents

Drug Target Review

7,9 Dihydrofolate reductase-thymidylate synthase (DHFR) have been successfully exploited for the therapy of bacterial infections and other parasitic diseases such as malaria. 2018): Silent Information Regulator 2 from Trypanosoma cruzi is a potential target to infection control, IntechOpen. 12(11): e0006980. Nilmar, S. and Anabela, C.

Drugs 110